CVS - CVS Health Corporation (CVS) Q1 2024 Earnings Call Transcript
2024-05-01 12:12:07 ET
CVS Health Corporation (CVS)
Q1 2024 Earnings Conference Call
May 1, 2024 08:00 a.m. ET
Company Participants
Karen Lynch - President, Chief Executive Officer
Tom Cowhey - Chief Financial Officer
David Falkowski - Executive Vice President, Chief Compliance Officer
Brian Kane - Executive Vice President, President, Aetna
Mike Pykosz - Executive Vice President, President of Health Care Delivery
Larry McGrath - Senior Vice President of Business Development, Investor Relations
Conference Call Participants
Justin Lake - Wolfe Research
Lisa Gill - J.P. Morgan
Nathan Rich - Goldman Sachs
Stephen Baxter - Wells Fargo
Michael Cherny - Leerink Partners
Josh Raskin - Nephron Research
Elizabeth Anderson - Evercore ISI
Ann Hynes - Mizuho Securities
Presentation
Operator
Hello and welcome to today's CVS Health Q1 2024 Earnings Conference Call. My name is Jordan and I'll be coordinating your call today. [Operator Instructions]. I'm now going to hand over to Larry McGrath to begin. Larry, please go ahead.
Larry McGrath
Good morning. Welcome to the CVS Health first quarter 2024 earnings call and webcast. I'm Larry McGrath, Senior Vice President of Business Development and Investor Relations for CVS Health. I'm joined this morning by Karen Lynch, President and Chief Executive Officer; and Tom Cowhey, Chief Financial Officer.
Following our prepared remarks, we'll host a question and answer session that will include additional members of our leadership team. Our press release and slide presentation have been posted to our website, along with our Form 10-Q filed this morning with the SEC. Today's call is also being broadcast on our website where it will be archived for one year.
During this call, we'll make certain forward-looking statements. Our forward-looking statements are subject to significant risks and uncertainties that could cause actual results to differ materially from currently projected results. We strongly encourage you to review the reports we file with the SEC regarding these risks and uncertainties.
In particular, those that are described in the cautionary statement concerning forward-looking statements and risk factors in our most recent Annual Report filed on Form 10-K, our quarterly report on Form 10-Q filed this morning, and our recent filings on Form 8-K, including this morning's earnings press release.
During this call, we'll use non-GAAP measures when talking about the company's financial performance and financial condition. You can find a reconciliation of these non-GAAP measures in this morning's press release and in the reconciliation document posted to the Investor Relations portion of our website.
With that, I'd like to turn the call over to Karen. Karen.
Karen Lynch
Thank you, Larry. Good morning, everyone. Thanks for joining our call today. This morning, we announced first-quarter results that were burdened by utilization pressures in Medicare Advantage, which materially impacted our healthcare benefit segment. ...
CVS Health Corporation (CVS) Q1 2024 Earnings Call Transcript